Antibodies are essential tools in biomedical research, helping scientists investigate disease mechanisms, validate therapeutic targets, and understand immune responses. Yet for many in vivo studies, finding the right antibody that is available, scalable, and suitable for animal research can become a significant barrier.
This whitepaper follows a collaborative effort to obtain a hard-to-access antibody for an in vivo study, highlighting how custom development strategies can help researchers advance translational immunology and infectious disease research.
Download this whitepaper to learn:
- Common challenges in antibody access and sourcing
- Key requirements for in vivo–ready antibodies
- Strategies for developing antibodies against difficult target
